ATE335764T1 - Spezifische antikörper gegen humanes choriongonadotropin hormone und deren verwendung in therapie und diagnose - Google Patents

Spezifische antikörper gegen humanes choriongonadotropin hormone und deren verwendung in therapie und diagnose

Info

Publication number
ATE335764T1
ATE335764T1 AT00935985T AT00935985T ATE335764T1 AT E335764 T1 ATE335764 T1 AT E335764T1 AT 00935985 T AT00935985 T AT 00935985T AT 00935985 T AT00935985 T AT 00935985T AT E335764 T1 ATE335764 T1 AT E335764T1
Authority
AT
Austria
Prior art keywords
hcg
diagnosis
therapy
antibodies against
specific antibodies
Prior art date
Application number
AT00935985T
Other languages
English (en)
Inventor
Patrick L Iversen
Original Assignee
Avi Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avi Biopharma Inc filed Critical Avi Biopharma Inc
Application granted granted Critical
Publication of ATE335764T1 publication Critical patent/ATE335764T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT00935985T 1999-05-17 2000-05-15 Spezifische antikörper gegen humanes choriongonadotropin hormone und deren verwendung in therapie und diagnose ATE335764T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13441999P 1999-05-17 1999-05-17
US13443299P 1999-05-17 1999-05-17

Publications (1)

Publication Number Publication Date
ATE335764T1 true ATE335764T1 (de) 2006-09-15

Family

ID=26832312

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00935985T ATE335764T1 (de) 1999-05-17 2000-05-15 Spezifische antikörper gegen humanes choriongonadotropin hormone und deren verwendung in therapie und diagnose

Country Status (10)

Country Link
US (1) US6764680B2 (de)
EP (1) EP1183275B1 (de)
JP (1) JP2003502025A (de)
KR (1) KR100684573B1 (de)
AT (1) ATE335764T1 (de)
AU (1) AU5136100A (de)
CA (1) CA2369397A1 (de)
DE (1) DE60029953T2 (de)
ES (1) ES2269150T3 (de)
WO (1) WO2000069915A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294171B2 (en) * 1999-09-14 2001-09-25 Milkhaus Laboratory, Inc. Methods for treating disease states comprising administration of low levels of antibodies
US8128922B2 (en) * 1999-10-20 2012-03-06 Johns Hopkins University Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
WO2004098526A2 (en) 2003-05-05 2004-11-18 Johns Hopkins University Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
WO2005005465A2 (en) * 2003-07-08 2005-01-20 Board Of Regents, University Of Texas System Methods and compositions to enhance immune responses via recall antigens
CA2538300A1 (en) * 2003-09-22 2005-03-31 Green Peptide Co., Ltd. Prognosis in cancer patients vaccinated with a cancer antigen peptide-associated agent
CA2505329C (en) * 2004-04-26 2013-01-22 General Mills Ip Holdings Ii, Llc Low sugar presweetened dry coated cereals and method of preparation
BRPI0511780A (pt) * 2004-06-03 2008-01-15 Hoffmann La Roche tratamento com oxoliplatina e um inibidor de egrf
EP1773402A2 (de) * 2004-06-17 2007-04-18 Mannkind Corporation Wirksamere immuntherapie mittels ergänzung diagnostischer verfahren mit therapeutischen verfahren
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
WO2007019541A2 (en) * 2005-08-08 2007-02-15 Onconon, Llc. Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
AR059922A1 (es) * 2006-04-01 2008-05-07 Galaxy Biotech Llc Anticuerpos monoclonales humanizados para el factor de crecimiento de hepatocitos
CN101314619B (zh) * 2007-06-01 2010-12-22 齐鲁制药有限公司 肿瘤治疗性疫苗ctp37crm197免疫原及其制备方法与应用
RU2481833C2 (ru) * 2008-01-18 2013-05-20 ХОРФАГ РИСЭЧ АйПи (эМАйА) эЛТиДи Композиция для уменьшения внутриглазного давления и способ профилактики или лечения высокого или патологического внутриглазного давления

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4691006A (en) 1983-03-04 1987-09-01 Ohio State University Antigenic modification of polypeptides
JPS60501271A (ja) * 1983-05-06 1985-08-08 ザ・トラステイ−ズ・オブ・コロンビア・ユニヴア−シテイ・イン・ザ・シテイ・オブ・ニユ−・ヨ−ク ヒト絨毛性ゴナドトロピンのイムノアツセイ
US6319504B1 (en) * 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin

Also Published As

Publication number Publication date
WO2000069915A3 (en) 2001-07-26
US20020164338A1 (en) 2002-11-07
ES2269150T3 (es) 2007-04-01
KR100684573B1 (ko) 2007-02-20
WO2000069915A2 (en) 2000-11-23
EP1183275B1 (de) 2006-08-09
DE60029953D1 (de) 2006-09-21
CA2369397A1 (en) 2000-11-23
US6764680B2 (en) 2004-07-20
JP2003502025A (ja) 2003-01-21
EP1183275A2 (de) 2002-03-06
KR20020007416A (ko) 2002-01-26
AU5136100A (en) 2000-12-05
DE60029953T2 (de) 2007-09-13

Similar Documents

Publication Publication Date Title
Naruse et al. Deposition of renal tubular epithelial antigen along the glomerular capillary walls of patients with membranous glomerulonephritis
DE3750389D1 (de) Antikörper gegen menschlichen progesteronrezeptor sowie diagnosematerial und -verfahren.
DE60029953D1 (de) Spezifische antikörper gegen humanes choriongonadotropin hormone und deren verwendung in therapie und diagnose
DE69028388D1 (de) Monoklonaler antikörper gegen ein neues humanes tumor assoziiertes antigen
ES2093778T3 (es) Nuevos anticuerpos y metodos para su uso.
IL142948A0 (en) Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases
AU5621396A (en) Reconstituted human antibody against human interleukin 6 receptor
DE69531148D1 (de) Bibliotheken aus polyklonalen antikörpern
JPH09505056A (ja) ヒトガストリン１７に対する改良された免疫原性組成物
ATE328611T1 (de) Multiple,kohlenhydrathaltige glycopeptid-antigene,daraus entwickelte impfstoffe sowie deren verwendung
AR033832A1 (es) Un metodo ex vivo para diagnosticar una enfermedad autoinmune, anticuerpo, composicion de diagnostico que lo comprende, y usos del anticuerpo
DE60129278D1 (de) Gegen das SEMP1-Protein gerichtete Antikörper, Verfahren zu deren Herstellung, und deren Anwendungen
Remy et al. Are antibodies responsible for a decreased superovulatory response in goats which have been treated repeatedly with porcine follicle-stimulating hormone?
SOKOL et al. Gonadotropin therapy failure secondary to human chorionic gonadotropin-induced antibodies
ATE442439T1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
SE7809249L (sv) Antigen for tidig graviditetsprovning och kontraceptivt vaccin
DE60141297D1 (de) Gegen das menschliche bst2 antigen gerichteter monoklonaler antikörper
ATE397659T1 (de) Polyklonale antikörper gegen den menschlichen alpha-pdgf-rezeptor und dessen verwendung
JPH01501793A (ja) 透明帯に対する免疫化による避妊のための方法
CA2074662A1 (en) Anti-idiotypic antibodies that mimic tnf
Butler et al. Effect of physical state and route of inoculation of diphtheria toxoid on the formation of nasal secretory and serum antibodies in man
JPS60138469A (ja) 腫瘍特異的免疫グロブリンの測定法
Nieschlag et al. Antigenicity of human chorionic gonadotrophin preparations in men
GB2314334A (en) Improved production of antibodies through the use of antigen antibody complexes
AU766457B2 (en) Antigenic modification of polypeptides

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties